**********Please Note: Optimal concentrations/dilutions should be determined by the end user.**********
Receptor expressed in lymphoid tissues (RELT), also known as tumor necrosis factor receptor superfamily, member 19-like (TNFRSF19L), is a member of the TNF-receptor superfamily. This receptor is especially abundant in hematologic tissues. It has been shown to activate the NF-kappaB pathway and selectively bind TNF receptor-associated factor 1. RELT/TNFRSF19L is capable of stimulating T-cell proliferation in the presence of CD3 signaling, which suggests its regulatory role in immune response. RELT/TNFRSF19L is a type I transmembrane glycoprotein with a cysteine-rich extracellular domain, possessing significant homology to other members of the TNFR superfamily, especially TNFRSF19, DR3, OX40, and LTbeta receptor. RELT/TNFRSF19L is able to activate the NF-kappaB pathway and selectively binds tumor necrosis factor receptor-associated factor 1. RELT/TNFRSF19L is able to activate the NF-κB pathway and selectively binds tumor necrosis factor receptor-associated factor 1. Although the soluble form of RELT fusion protein does not inhibit the one-way mixed lymphocyte reaction, immobilized RELT/TNFRSF19L is capable of costimulating T-cell proliferation in the presence of CD3 signaling.
|Product Description||Host||Clonality||Application||Catalog# (PDF)|
|Anti-RELT / TNFRSF19L Antibody||Rabbit||Monoclonal||ELISA(Cap)||10530-R111|
|Anti-RELT / TNFRSF19L Antibody||Rabbit||Monoclonal||ELISA,ELISA(Det)||10530-R135|
|Anti-RELT / TNFRSF19L Antibody||Rabbit||Polyclonal||ELISA||10530-RP01|
|Anti-RELT / TNFRSF19L Antibody||Mouse||Monoclonal||ICC/IF,IF||10530-MM01|